Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy

Pharmacology and Therapeutics

Volumn 110, Issue 1, 2006, Pages 57-70

  Corti, Roberto ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Arteriosclerosis; Imaging; Magnetic resonance; Plaques; Therapy

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESTIPOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; S 18886; SIMVASTATIN; THROMBOXANE; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ARTERY THROMBOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; BLOOD VESSEL WALL; BRACHYTHERAPY; CALCIFICATION; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; DRUG DOSE REGIMEN; DRUG INHIBITION; FIBROSIS; HUMAN; HYPERLIPIDEMIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, CARDIOVASCULAR; TREATMENT OUTCOME;

EID: 32844470958     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.09.004     Document Type: Review

References (79)

1. O.F. Bertrand, S. Lehnert, R. Mongrain, and M.G. Bourassa Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal Heart 82 6 1999 658 662
2. O.F. Bertrand, D. Meerkin, and R. Bonan Coronary aneurysm after endovascular brachytherapy: true or false? Circulation 102 18 2000 E121
3. R. Bonvini, I. Baumgartner, D. Do do, M. Alerci, J.M. Segatto, and P. Tutta Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries J Am Coll Cardiol 41 3 2003 409 412
4. R.M. Botnar, M. Stuber, P.G. Danias, K.V. Kissinger, and W.J. Manning Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA Circulation 99 24 1999 3139 3148
5. R.M. Botnar, M. Stuber, K.V. Kissinger, W.Y. Kim, E. Spuentrup, and W.J. Manning Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging Circulation 102 21 2000 2582 2587
6. R.M. Botnar, W.Y. Kim, P. Bornert, M. Stuber, E. Spuentrup, and W.J. Manning 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition Magn Reson Med 46 5 2001 848 854
7. G. Chinetti, F.G. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, and P. Poulain CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors Circulation 101 20 2000 2411 2417
8. R.P. Choudhury, V. Fuster, and Z.A. Fayad Molecular, cellular and functional imaging of atherothrombosis Nat Rev Drug Discov 3 11 2004 913 925
9. R. Corti, and J.J. Badimon Biologic aspects of vulnerable plaque Curr Opin Cardiol 17 6 2002 616 625
10. R. Corti, and V. Fuster New understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging Am J Cardiol 91 3A 2003 17A 26A
11. R. Corti, Z.A. Fayad, V. Fuster, S.G. Worthley, G. Helft, and J. Chesebro Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging Circulation 104 3 2001 249 252
12. R. Corti, V. Fuster, J.J. Badimon, R. Hutter, and Z.A. Fayad New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo Ann N Y Acad Sci 947 2001 181 195 (discussion 195-8)
13. R. Corti, V. Fuster, and J.J. Badimon Strategy for ensuring a better future for the vessel wall Eur Heart J 4 Suppl 4 2002 A31 A41
14. R. Corti, V. Fuster, Z.A. Fayad, S.G. Worthley, G. Helft, and D. Smith Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging Circulation 106 23 2002 2884 2887
15. R. Corti, R. Wyttenbach, M. Alerci, J.J. Badimon, V. Fuster, and A. Gallino Images in cardiovascular medicine. Effect of percutaneous transluminal angioplasty on severely stenotic femoral lesions: in vivo demonstration by noninvasive magnetic resonance imaging Circulation 106 12 2002 1570 1571
16. R. Corti, J.I. Osende, J.T. Fallon, V. Fuster, G. Mizsei, and H. Jneid The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging J Am Coll Cardiol 43 3 2004 464 473
17. R. Corti, V. Fuster, Z.A. Fayad, S.G. Worthley, G. Helft, and W.F. Chaplin Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial by high-resolution Magnetic Resonance Imaging J Am Coll Cardiol 5 46 2005 106 112
18. R.A. Coulden, H. Moss, M.J. Graves, D.J. Lomas, D.S. Appleton, and P.L. Weissberg High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty Heart 83 2 2000 188 191
19. M.J. Davies Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995 Circulation 94 8 1996 2013 2020
20. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 3 1995 657 671
21. Z.A. Fayad, and V. Fuster Clinical imaging of the high-risk or vulnerable atherosclerotic plaque Circ Res 89 4 2001 305 316
22. Z.A. Fayad, J.T. Fallon, M. Shinnar, S. Wehrli, H.M. Dansky, and M. Poon Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice Circulation 98 15 1998 1541 1547
23. Z.A. Fayad, V. Fuster, J.T. Fallon, T. Jayasundera, S.G. Worthley, and G. Helft Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging Circulation 102 5 2000 506 510
24. Z.A. Fayad, T. Nahar, J.T. Fallon, M. Goldman, J.G. Aguinaldo, and J.J. Badimon In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography Circulation 101 21 2000 2503 2509
25. J.C. Frias, K.J. Williams, E.A. Fisher, and Z.A. Fayad Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques J Am Chem Soc 126 50 2004 16316 16317
26. V. Fuster, Z.A. Fayad, and J.J. Badimon Acute coronary syndromes: biology Lancet 353 Suppl 2 1999 SII5 SII9
27. S. Glagov, E. Weisenberg, C.K. Zarins, R. Stankunavicius, and G.J. Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 22 1987 1371 1375
28. T. Hagenaars, A.P. IF, M.R. van Sambeek, V.L. Coen, R.B. Van Tongeren, and F.M. Gescher Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study J Vasc Surg 36 2 2002 318 324
29. T.S. Hatsukami, R. Ross, N.L. Polissar, and C. Yuan Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging Circulation 102 9 2000 959 964
30. G. Helft, S.G. Worthley, V. Fuster, A.G. Zaman, C. Schechter, and J. Osende Atherosclerotic aortic component quantification by noninvasive magnetic resonance: an in vivo study in rabbits J Am Coll Cardiol 37 2001 1149 1154
31. G. Helft, S.G. Worthley, V. Fuster, A.G. Zaman, C. Schechter, and J.I. Osende Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits J Am Coll Cardiol 37 4 2001 1149 1154
32. W.A. Hsueh, S. Jackson, and R.E. Law Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes Diabetes Care 24 2 2001 392 397
33. F.A. Jaffer, C.J. O'Donnell, K.V. Kissinger, S.K. Chan, R.M. Botnar, and R.R. Edelman MRI assessment of aortic atherosclerosis in an asymptomatic population: the Framingham Heart Study Circulation 102 2000 II 458
34. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 6662 1998 82 86
35. C.M. Kramer, L.A. Cerilli, K. Hagspiel, J.M. DiMaria, F.H. Epstein, and J.A. Kern Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm Circulation 109 8 2004 1016 1021
36. S.E. Langerak, H.W. Vliegen, A. de Roos, A.H. Zwinderman, J.W. Jukema, and P. Kunz Detection of vein graft disease using high-resolution magnetic resonance angiography Circulation 105 3 2002 328 333
37. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 9 2002 1135 1143
38. J.A. Lima, M.Y. Desai, H. Steen, W.P. Warren, S. Gautam, and S. Lai Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy Circulation 110 16 2004 2336 2341
39. N. Marx, T. Bourcier, G.K. Sukhova, P. Libby, and J. Plutzky PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease Arterioscler Thromb Vasc Biol 19 3 1999 546 551
40. C.H. Maynor, H.C. Charles, R.J. Herfkens, S.A. Suddarth, and G.A. Johnson Chemical shift imaging of atherosclerosis at 7.0 Tesla Invest Radiol 24 1 1989 52 60
41. M.V. McConnell, M. Aikawa, S.E. Maier, P. Ganz, P. Libby, and R.T. Lee MRI of rabbit atherosclerosis in response to dietary cholesterol lowering Arterioscler Thromb Vasc Biol 19 8 1999 1956 1959
42. D. Meerkin, J.C. Tardif, O.F. Bertrand, J. Vincent, F. Harel, and R. Bonan The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections J Am Coll Cardiol 36 1 2000 59 64
43. E. Minar, R. Wolfram, and B. Pokrajac Endovascular brachytherapy and late thrombotic occlusion Circulation 102 22 2000 E175 E176
44. P.R. Moreno, K.R. Purushothaman, V. Fuster, and W.N. O'Connor Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability Circulation 105 21 2002 2504 2511
45. C.J. O'Donnell, M.G. Larson, F.A. Jaffer, K.V. Kissinger, D. Levy, and W.J. Manning Aortic atherosclerosis detected by MRI is associated with contemporaneous and longitudinal risk factors: the Framingham Heart Study (FHS) Circulation 102 2000 II 836
46. V. Pasceri, H.D. Wu, J.T. Willerson, and E.T. Yeh Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators Circulation 101 3 2000 235 238
47. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 6662 1998 79 82
48. S.G. Ruehm, M. Goyen, J. Barkhausen, K. Kroger, S. Bosk, and M.E. Ladd Rapid magnetic resonance angiography for detection of atherosclerosis Lancet 357 9262 2001 1086 1091
49. R.L. Sacco Clinical practice. Extracranial carotid stenosis N Engl J Med 345 15 2001 1113 1118
50. H. Satoh, K. Tsukamoto, Y. Hashimoto, N. Hashimoto, M. Togo, and M. Hara Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function Biochem Biophys Res Commun 254 3 1999 757 763
51. M. Shinnar, J.T. Fallon, S. Wehrli, M. Levin, D. Dalmacy, and Z.A. Fayad The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization Arterioscler Thromb Vasc Biol 19 11 1999 2756 2761
52. M.P. Skinner, C. Yuan, L. Mitsumori, C.E. Hayes, E.W. Raines, and J.A. Nelson Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo Nat Med 1 1 1995 69 73
53. K. Soila, P. Nummi, T. Ekfors, M. Viamonte Jr., and M. Kormano Proton relaxation times in arterial wall and atheromatous lesions in man Invest Radiol 21 5 1986 411 415
54. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, and W. Insull Jr. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 92 5 1995 1355 1374
55. M. Stuber, R.M. Botnar, P.G. Danias, D.K. Sodickson, K.V. Kissinger, and M. Van Cauteren Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography J Am Coll Cardiol 34 2 1999 524 531 [in process citation]
56. M. Stuber, R.M. Botnar, E. Spuentrup, K.V. Kissinger, and W.J. Manning Three-dimensional high-resolution fast spin-echo coronary magnetic resonance angiography Magn Reson Med 45 2 2001 206 211
57. R.M. Summers, J. Andrasko-Bourgeois, I.M. Feuerstein, S.C. Hill, E.C. Jones, and M.K. Busse Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia Circulation 98 6 1998 509 518
58. H. Taniguchi, Y. Momiyama, Z.A. Fayad, R. Ohmori, K. Ashida, and T. Kihara In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography Am Heart J 148 1 2004 137 143
59. E.J. Topol, and S.E. Nissen Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease Circulation 92 8 1995 2333 2342
60. J.F. Toussaint, J.F. Southern, V. Fuster, and H.L. Kantor 13C-NMR spectroscopy of human atherosclerotic lesions. Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction Arterioscler Thromb 14 12 1994 1951 1957
61. J.F. Toussaint, J.F. Southern, V. Fuster, and H.L. Kantor T2-weighted contrast for NMR characterization of human atherosclerosis Arterioscler Thromb Vasc Biol 15 10 1995 1533 1542
62. J.F. Toussaint, J.F. Southern, V. Fuster, and H.L. Kantor Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance Arterioscler Thromb Vasc Biol 17 3 1997 542 546
63. J.F. Toussaint, G.M. LaMuraglia, J.F. Southern, V. Fuster, and H.L. Kantor Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo Circulation 94 5 1996 932 938
64. J.F. Toussaint, H. Gouya, D. Glurton, P. Fornes, G.P.M. Berger, and J. Bittoun A T2 classification for the discrimination of atheromatous primary and restenotic coronary plaques at 1.5T by high-resolution MRI Proc Int Soc Magn Reson Med 1 1999 84
65. J.F. Viles-Gonzalez, V. Fuster, R. Corti, C. Valdiviezo, R. Hutter, and S. Corda The selective inhibition of thromboxane A2 receptor has antiatherosclerotic and plaque stabilizing effects: follow-up with serial high resolution magnetic resonance imaging Eur Heart J 26 15 2005 1557 1561
66. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 5 2000 1262 1275
67. J.A. Ware Too many vessels? Not enough? The wrong kind? The VEGF debate continues Nat Med 7 4 2001 403 404
68. J.J. Wentzel, R. Corti, Z.A. Fayad, P. Wisdom, F. Macaluso, and M.O. Winkelman Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging J Am Coll Cardiol 45 6 2005 846 854
69. S.G. Worthley, G. Helft, V. Fuster, Z.A. Fayad, J.T. Fallon, and J.I. Osende High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model Atherosclerosis 150 2 2000 321 329
70. S.G. Worthley, G. Helft, V. Fuster, Z.A. Fayad, O.J. Rodriguez, and A.G. Zaman Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model Circulation 101 25 2000 2956 2961
71. S.G. Worthley, G. Helft, V. Fuster, A.G. Zaman, Z.A. Fayad, and J.T. Fallon Serial In vivo MRI documents arterial remodeling in experimental atherosclerosis Circulation 101 6 2000 586 589
72. R. Wyttenbach, A. Gallino, M. Alerci, F. Mahler, L. Cozzi, and M. Di Valentino Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging Circulation 110 9 2004 1156 1161
73. A. Yonemura, Y. Momiyama, Z.A. Fayad, M. Ayaori, R. Ohmori, and K. Higashi Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging J Am Coll Cardiol 45 5 2005 733 742
74. C. Yuan, K.W. Beach, L.H. Smith Jr., and T.S. Hatsukami Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging Circulation 98 24 1998 2666 2671
75. C. Yuan, L.M. Mitsumori, K.W. Beach, and K.R. Maravilla Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions Radiology 221 2 2001 285 299
76. C. Yuan, L.M. Mitsumori, M.S. Ferguson, N.L. Polissar, D. Echelard, and G. Ortiz In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques Circulation 104 17 2001 2051 2056
77. C. Yuan, W.S. Kerwin, M.S. Ferguson, N. Polissar, S. Zhang, and J. Cai Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization J Magn Reson Imaging 15 1 2002 62 67
78. C. Yuan, S.X. Zhang, N.L. Polissar, D. Echelard, G. Ortiz, and J.W. Davis Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke Circulation 105 2 2002 181 185
79. X.Q. Zhao, C. Yuan, T.S. Hatsukami, E.H. Frechette, X.J. Kang, and K.R. Maravilla Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study Arterioscler Thromb Vasc Biol 21 10 2001 1623 1639